Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
Financings

Unidoc Health amends LIFE offering

UDOC · Price

Executive Summary

  • Unidoc Health Corp. has amended the terms of its previously announced non-brokered private placement LIFE offering to establish a minimum offering amount.
  • The offering now requires a minimum of 5,333,333 units for gross proceeds of $800,000, with a maximum capacity of 10 million units for gross proceeds of up to $1.5 million.
  • The company intends to use the proceeds for inventory, marketing, investor relations, working capital, and general corporate purposes.

Key Details

  • Offering Structure: Non-brokered private placement under the Listed Issuer Financing Exemption (LIFE).
  • Minimum Offering: 5,333,333 units.
  • Maximum Offering: 10,000,000 units.
  • Price Per Unit: 15 cents.
  • Minimum Gross Proceeds: $800,000.
  • Maximum Gross Proceeds: $1,500,000.
  • Unit Composition: Each unit consists of one common share and one transferable common share purchase warrant.
  • Warrant Terms: Each warrant entitles the holder to acquire one additional common share at an exercise price of 25 cents.
  • Warrant Expiry: 36 months following the closing of the offering.
  • Use of Proceeds: Inventory, marketing, investor relations services, working capital, and general corporate purposes.
  • Jurisdiction: Offered in all Canadian provinces and territories excluding Quebec.
  • Resale Restrictions: Securities issued to Canadian resident subscribers are not subject to resale restrictions pursuant to NI 45-106.
  • Closing Date: Expected on or about October 22, 2025, or within 45 days from October 17, 2025.
  • Conditions: Subject to customary conditions, including approval from the Canadian Securities Exchange.
  • Documentation: An amended and restated offering document is available on SEDAR+ and the company's website.
Read the original news release →

More from Unidoc Health Corp